Legislation Year: 2018
Pre-exposure prophylaxis (PrEP) is an antiretroviral medication that has been shown to be safe and effective in reducing the risk of acquiring HIV among people who are at high risk of acquiring the virus. PrEP is estimated to be over 90 percent effective at preventing HIV infection, but only about 12 percent of the 1.2 million Americans at high risk for HIV exposure are using PrEP. This resolution recognizes August 16, 2018, as Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis Awareness Day in California to enhance public awareness of PrEP and PEP.
Keywords: